Sign in

You're signed outSign in or to get full access.

Thomas N. Bohjalian

Chairman of the Board at Healthcare Realty Trust
Board

About Thomas N. Bohjalian

Independent Chair of the Board at Healthcare Realty Trust (HR); age 59; director since 2024. Former Executive Vice President and Senior Portfolio Manager at Cohen & Steers (Head of U.S. Real Estate & Trading), overseeing $40B of the firm’s $90B in assets; prior public company board service at Apartment Income REIT (Dec 2021–Jun 2024); Senior Real Estate Advisor to PropTech firm BeyondView since 2022. Core credentials emphasize investment management, capital markets, corporate finance, risk oversight, and compensation governance .

Past Roles

OrganizationRoleTenureCommittees/Impact
Cohen & SteersEVP, Senior Portfolio Manager; Head of U.S. Real Estate & TradingMay 2002–Jun 2021Oversight of ~$40B of firm assets; brings capital markets and investment strategy insight to HR .
Apartment Income REITDirectorDec 2021–Jun 2024Public REIT board experience; informs real estate and governance perspectives .

External Roles

OrganizationRoleTenureFocus
BeyondView (PropTech)Senior Real Estate AdvisorSince 2022Digital twins for commercial real estate; technology-informed real estate insights .

Board Governance

  • Role and independence
    • Independent Chair of the Board; CEO role held separately by Interim CEO Constance B. Moore, supporting oversight and management accountability .
    • Board determined that all directors and nominees are independent except Ms. Moore (interim CEO) .
  • Committee memberships and engagement
    • Compensation & Human Capital Committee member; Committee met 15 times in 2024 .
    • Capital Allocation Committee member; Committee met 10 times in 2024 .
    • CEO Search Committee member (formed Nov 2024): Rufrano (chair), Bohjalian, Henry, Moore .
  • Attendance and executive sessions
    • Board held 29 meetings in 2024; each director attended ≥75% of relevant meetings .
    • Independent directors held 17 executive sessions in 2024; the independent Chair presides .
  • Related-party oversight and conflicts policy
    • Robust related-party transaction policy under Nominating & Corporate Governance Committee; no reportable related-party transactions in 2024 .

Fixed Compensation

ComponentAmountNotes
Fees Earned or Paid in Cash (2024)$63,250Includes committee chair/member fees and meeting fees as applicable .
Stock Awards (2024)$135,003Grant-date fair value of restricted stock .
Total (2024)$198,253Sum of cash fees and stock awards .

Director compensation structure (May 2024–May 2025 term):

  • Annual cash retainer: $80,000; Independent chair additional retainer: $150,000 .
  • Committee retainers: Audit Chair $30,000; Audit Member $10,000; Compensation Chair $22,500; Compensation Member $7,500; Nominating Chair $22,500; Nominating Member $7,500; Capital Allocation Chair $22,500; Capital Allocation Member $7,500 .
  • Equity grant: Annual restricted stock grant with $135,000 market value at grant date; meeting fees apply after thresholds (>$1,500 per meeting after 6 in CY2024; after 10 in CY2025) .

Performance Compensation

ElementTermsPerformance Metrics
Director equityRestricted shares of common stockTime-based vesting (1 year); directors may elect to take cash retainer as restricted stock at 1.1x multiple; no performance conditions disclosed for director equity .
Company executive performance framework (for pay-for-performance oversight)RSUs (2022) measured on Absolute TSR (18%), Relative TSR (12%), FFO/share (20%), FAD/share (20%); OP Units (2023): Relative TSR, FAD/share; OP Units (2024): Relative TSR (25%), FAD/share (20%), 3-yr Multi-tenant Occupancy (15%), Payout Ratio (10%)2022 RSUs earned below threshold across all metrics; 2023 OP Units tracking below target; 2024 OP Units tracking at target at 33% complete .

Committee methodology and investor feedback signals:

  • 2024 say‑on‑pay support: 75.3%; prior five-year average 95.1%; in response, 2025 program simplified cash metrics and equity performance awards focus on TSR with rigorous relative and absolute hurdles .
  • Compensation benchmarking peer group refined in 2025 (removed largest peers; size-based comparability) .

Other Directorships & Interlocks

CompanyRoleTenureInterlocks/Notes
Apartment Income REITDirectorDec 2021–Jun 2024Prior REIT board service; enhances sector expertise .
Compensation Committee Interlocks at HRN/A2024No interlocks among Committee members (includes Bohjalian) .

Potential network signals:

  • Cohen & Steers Inc. beneficial owner of 17.16% of HR common stock; Bohjalian is retired (since 2021) from Cohen & Steers; Board affirms independence and no related-party transactions in 2024 .

Expertise & Qualifications

  • Investment management and capital markets leadership (Cohen & Steers head of U.S. Real Estate & Trading; investment management skill marked) .
  • Finance and accounting, corporate finance, risk management, compensation, and corporate governance competencies (Board core skills matrix) .
  • Real estate sector depth; advisory role in PropTech (BeyondView) .

Equity Ownership

HolderCommon Shares Beneficially Owned% of OutstandingNotes
Thomas N. Bohjalian54,002<1%Includes restricted shares; HR outstanding shares: 350,996,169 (as of Mar 27, 2025) .

Stock ownership guidelines and compliance:

  • Non‑employee directors must hold stock equal to 3x the annual retainer; as of Mar 27, 2025, all non‑employee directors met the guidelines except Henry, Rufrano, Wood (new appointees) .

Insider Trades (Section 16 compliance)

ItemStatusPeriod
Section 16(a) filings by directors and officersAll timely filed; no delinquencies reported2024 .

Governance Assessment

  • Strengths
    • Independent Chair with separation from CEO role; presides over 17 executive sessions, improving oversight and board effectiveness .
    • Active roles on Compensation & Human Capital and Capital Allocation Committees; participation on CEO Search Committee during management transitions indicates high engagement .
    • Strong pay‑for‑performance posture overseen by Compensation Committee: multi‑metric equity awards; below‑threshold outcomes for 2022 RSUs; 2025 program tightened to TSR‑only with rigorous hurdles; peer group refined; responsiveness to a lower 2024 say‑on‑pay vote .
    • Ownership alignment: 54,002 shares; compliance with director stock ownership guidelines; option to take cash retainer in stock at 1.1x multiple .
    • Controls and conflicts: formal related‑party review process; no reportable related‑party transactions in 2024; all Section 16 filings timely .
  • Watch items / potential conflicts
    • Former senior executive at Cohen & Steers, a 17.16% HR shareholder; independence affirmed by Board and no related‑party transactions reported, but investors may monitor for perceived influence on capital allocation or governance decisions .
    • Management turnover in late 2024 (CEO and CFO): mitigated by CEO search committee and board engagement; continue monitoring for stability and pay practices alignment under revised 2025 framework .